Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04593888
NA

Gluten Reduction and Risk of Celiac Disease

Sponsor: Lund University

View on ClinicalTrials.gov

Summary

Celiac disease shares many features of other autoimmune diseases such as type 1 diabetes. Recently, it was published that higher amounts of gluten intake increased the risk for celiac disease. Optimal amounts of gluten to be introduced during weaning have not yet been established. The aim is to investigate if a gluten-restricted diet (e.g. below 3 gram per day) during the first 3 years of life will reduce the risk of develop CDA and IA in genetically predisposed children by the age of 7 years. Children who screened positive for HLA DQ2/X (X is neither DQ2 nor DQ8) in the GPPAD-02 (ASTR1D \[ClinicalTrials.gov Identifier NCT03316261\]) screening will be contacted by a study nurse.

Official title: Gluten Reduction After Infancy and Risk of Celiac Disease

Key Details

Gender

All

Age Range

6 Months - 6 Months

Study Type

INTERVENTIONAL

Enrollment

1141

Start Date

2021-05-05

Completion Date

2035-12-31

Last Updated

2025-08-19

Healthy Volunteers

No

Interventions

BEHAVIORAL

Gluten reduced diet

Dietary advice focusing on reducing gluten intake in children

Locations (1)

Clinical Research Center (CRC), Bldng 60:11

Malmo, Sweden